UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 6
June-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2506844


Registration ID:
565526

Page Number

i335-i339

Share This Article


Jetir RMS

Title

Drug–Drug Interactions in Polypharmacy: A Clinical Review of Mechanisms, Risk Management, and Clinical Pharmacist Interventions

Abstract

Polypharmacy, commonly defined as the concurrent use of five or more medications, is increasingly prevalent among elderly and chronically ill patients. polypharmacy is sometimes required to treat complicated health disorders, it considerably increases the risk of drug-drug interactions (DDIs), which can lead to reduced therapeutic efficacy, toxicity, or serious adverse drug reactions. This review investigates the pharmacokinetic and pharmacodynamic mechanisms underpinning DDIs and identifies the primary risk variables that contribute to clinically significant interactions. Real-world instances, such as warfarin-azithromycin or ACE inhibitors with potassium-sparing diuretics, highlight the potential severity of these events. Pharmacist interventions, including dose adjustments, deprescribing strategies, and the use of interaction-checker tools, contribute significantly to enhancing patient safety. Additionally, the implementation of electronic prescribing systems, interdisciplinary collaboration, and continuous monitoring are essential in minimizing DDI-related harm. Recognizing and addressing DDIs within polypharmacy is a key responsibility in modern healthcare, with clinical pharmacists serving as frontline guardians of safe medication use.

Key Words

Polypharmacy, Drug Interactions, Pharmacist Interventions, Adverse Drug Reactions, Risk Management, Patient Safety

Cite This Article

"Drug–Drug Interactions in Polypharmacy: A Clinical Review of Mechanisms, Risk Management, and Clinical Pharmacist Interventions", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 6, page no.i335-i339, June-2025, Available :http://www.jetir.org/papers/JETIR2506844.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Drug–Drug Interactions in Polypharmacy: A Clinical Review of Mechanisms, Risk Management, and Clinical Pharmacist Interventions", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 6, page no. ppi335-i339, June-2025, Available at : http://www.jetir.org/papers/JETIR2506844.pdf

Publication Details

Published Paper ID: JETIR2506844
Registration ID: 565526
Published In: Volume 12 | Issue 6 | Year June-2025
DOI (Digital Object Identifier):
Page No: i335-i339
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000169

Print This Page

Current Call For Paper

Jetir RMS